Commonwealth Coat of Arms of Australia

 

Health Insurance Legislation Amendment (2025 Measures No. 2) Determination 2025  

I, Mary Warner, delegate of the Minister for Health and Ageing, make the following Determination.

Dated  26 May 2025 

Mary Warner

Assistant Secretary

Diagnostic Imaging and Pathology Branch

Medicare Benefits and Digital Health Division

Health Resourcing Group

Department of Health, Disability and Ageing

 

1  Name...................................................1

2  Commencement............................................1

3  Authority................................................1

4  Schedules................................................1

Schedule 1— Co-Dependent Pathology Services Amendments 2

Health Insurance (Section 3C Co-Dependent Pathology Services) Determination 2018 2

Schedule 2— Pathologist-determinable Services Amendments 3

Health Insurance (Pathologist-determinable Services) Determination 2015 3

   

  This instrument is the Health Insurance Legislation Amendment (2025 Measures No.2) Determination 2025.

  1.     Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information 

Column 1 

Column 2 

Column 3 

Provisions 

Commencement 

Date/Details 

1.  The whole of this instrument 

1 July 2025.

 1 July 2025

  Note:     This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument. 

  1.     Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

  This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

 

  1.         Schedule 1 (after item 73307)

Insert:

73319

Detection in tumour tissue of isocitrate dehydrogenase 1 (IDH1) variant status, in a patient with histologically confirmed cholangiocarcinoma, to determine eligibility for a relevant treatment listed under the Pharmaceutical Benefits Scheme.

 

Applicable only once per lifetime

340.00

 

  1.         Section 5, table at subparagraph (b)(iii), (cell at item 1, column 1) 

Insert “73319” after “, 72852”.

  1.         Section 5, table at subparagraph (b)(iii), (Note under table)

Insert “73319” after “, 72860”.